Clinical trial
Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease
NCT00084409 · University of Colorado, Denver, Other · Completed
Key facts
| NCT number | NCT00084409 |
|---|---|
| Title | Iloprost in Preventing Lung Cancer in Patients at High Risk for This Disease |
| Official title | A Randomized Phase II Chemoprevention Study of Iloprost Versus Placebo in Patients at High Risk for Lung Cancer |
| Lead sponsor | University of Colorado, Denver, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer, Precancerous Condition |
| Intervention type | Drug, Other |
| Interventions | iloprost, placebo |
| Enrollment | 152 |
| Start date | Nov 1, 2001 |
| Primary completion | Jan 1, 2009 |
| Completion | Jan 1, 2009 |
| First posted | Jun 11, 2004 |
| Last update posted | May 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: